Featured news in The Life Sciences Report



Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Mylan's Proposed Biosimailar for Cancer Under Review in U.S. (2/17/2017)

view
 

Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View (2/17/2017)

view
 


Viveve Medical Inc. (VIVE:NASDAQ)
Viveve Reports Fourth Quarter and Full Year 2016 Financial Results (2/16/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Announces Release Date for 2016 Full Year Results (2/16/2017)

view
 


Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y (2/16/2017)

view
 

Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Agios Pharma (AGIO) Q4 Loss Narrower than Expected; Stock Up (2/17/2017)

view
 

Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Alkermes (ALKS) Q4 Loss Narrower than Expectations, Sales Beat (2/16/2017)

view
 

Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook (2/16/2017)

view
 


3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE)
3D Signatures Inc. Adds Medical Diagnostic Expert to Business Advisory Board (2/15/2017)

view
 


Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4 (2/15/2017)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Durable Responses and Sustained Low Disease Activity Over Nine Months After a Single Dose of Mesoblast Cell Therapy in Rheumatoid Arthritis Patients Resistant to Anti-TNF Agents (2/15/2017)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
City of Hope to Manufacture NurOwn® for Brainstorm's Phase 3 ALS Clinical Trial (2/16/2017)

view